Winding back the harms of too much medicine: Re-Check joined the 5th Preventing Overdiagnosis Conference in Québec City

By | September 4th, 2017|Categories: Adverse effects - Effets indésirables, Approvals - Homologations, Breast cancer screening - Dépistage du cancer du sein, Clinical trials - Essais cliniques, Endometriosis - Endométriose, HPV - HPV/VPH, HPV vaccine - Vaccination anti-HPV, Overdiagnosis - Surdiagnostic|

Catherine Riva of Re-Check was selected by the organizers of the Conference to present the results of her investigation on the “mammo-business”, an extensive system of business models and careers building grown in Switzerland around mammography screening. Her long-form investigative piece was honored in 2014 with a Media Award of the Swiss Academies of Medical Sciences. [...]